about
The E3 ligase Itch and deubiquitinase Cyld act together to regulate Tak1 and inflammationCYLD negatively regulates cell-cycle progression by inactivating HDAC6 and increasing the levels of acetylated tubulinDefining the human deubiquitinating enzyme interaction landscapeDUBbing Cancer: Deubiquitylating Enzymes Involved in Epigenetics, DNA Damage and the Cell Cycle As Therapeutic TargetsThe deubiquitinating enzyme complex BRISC is required for proper mitotic spindle assembly in mammalian cellsMolecular basis for specificity of the Met1-linked polyubiquitin signalPLK1, A Potential Target for Cancer TherapySystematic survey of deubiquitinase localization identifies USP21 as a regulator of centrosome- and microtubule-associated functionsA systems analysis of the chemosensitivity of breast cancer cells to the polyamine analogue PG-11047.The scaffold protein TANK/I-TRAF inhibits NF-kappaB activation by recruiting polo-like kinase 1.CYLD regulates RhoA activity by modulating LARG ubiquitination.Cylindroma transforming into basal cell carcinoma in a patient with Brooke-Spiegler syndromeCYLD Regulates Noscapine Activity in Acute Lymphoblastic Leukemia via a Microtubule-Dependent Mechanism.CYLD-mediated signaling and diseases.Update of cylindromatosis gene (CYLD) mutations in Brooke-Spiegler syndrome: novel insights into the role of deubiquitination in cell signalingDeubiquitinases in cancer.The deubiquitylase USP37 links REST to the control of p27 stability and cell proliferationThe TRAF-interacting protein (TRAIP) is a novel E2F target with peak expression in mitosisCYLD inhibits melanoma growth and progression through suppression of the JNK/AP-1 and β1-integrin signaling pathwaysDermal cylindroma of the scalp.Deciphering histone 2A deubiquitinationReverse the curse--the role of deubiquitination in cell cycle control.Deubiquitylation and regulation of the immune response.Functional interplay between cylindromatosis and histone deacetylase 6 in ciliary homeostasis revealed by phenotypic analysis of double knockout mice.The multiple layers of ubiquitin-dependent cell cycle control.CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes.DUBs at a glance.CYLD regulates spindle orientation by stabilizing astral microtubules and promoting dishevelled-NuMA-dynein/dynactin complex formation.The deubiquitinase USP54 is overexpressed in colorectal cancer stem cells and promotes intestinal tumorigenesis.Deubiquitinases in the regulation of NF-κB signaling.CYLD: a deubiquitination enzyme with multiple roles in cancer.Ubiquitin-specific proteases as cancer drug targets.Regulation of NF-κB by deubiquitinases.The role of the TRAF-interacting protein in proliferation and differentiation.Decoding ubiquitin for mitosis.Genetic and microbial factors modulating the ubiquitin proteasome system in inflammatory bowel disease.Cell death and deubiquitinases: perspectives in cancer.Role of the ubiquitin proteasome system in hematologic malignancies.Dysregulated TRK signalling is a therapeutic target in CYLD defective tumours.The ubiquitin-proteasome system and chromosome 17 in cerebellar granule cells and medulloblastoma subgroups.
P2860
Q24296068-C8403784-3745-419E-AF62-C0E0D8F3D266Q24314876-F5B083BB-5A83-45A1-89E2-A48A09BD7859Q24315885-226BA2A5-4FAD-4662-8BCB-AF8E9FC9841FQ26741797-B910F65A-B447-4005-B0F7-6EB9D2C9A5CEQ27309976-7A3EF2A4-DEFF-42E2-915C-54496BDCD681Q28072740-3B62056C-A12F-4002-A215-59D73135EE1AQ28078772-FA92DE16-325F-45C1-8C04-B00C5E6B8EDEQ28575853-9C06F3A5-6715-4DF8-B51F-718CE96227B2Q33517982-03E94701-6B17-4E1D-801E-68226957E4CCQ33992585-CA6A3246-1B56-4036-9C05-449B60A8F46CQ34584522-7245433E-08F5-46DC-A1BC-FD876344C636Q35169695-E1F80DA1-46A4-4DE7-B02E-78F0CD4615A0Q35475874-A42502F6-CA25-4DBA-867B-1AD201B45917Q35565726-B3CA5452-1FBF-496E-A4AD-A85276EF4470Q35625506-B03B7DDF-9F75-4636-AFC0-152FF9571927Q35955141-C893F1D6-6BC0-4A64-B1A8-DEBFF3F1EB02Q36213657-5FD12767-9EA8-4A1C-A0FF-C0CE93490FDFQ36356204-03B90BCD-65AE-416F-A934-640580E983E1Q36360760-46058142-012D-4319-B8F0-7F68BBD7E50CQ36443508-738158F5-5B6D-4893-8205-14AC44B44A63Q37069551-506A9141-D1E2-4998-84B6-0BE39F87AFADQ37112275-0460799F-A086-4073-B6AC-4135852D7B1EQ37184075-E4411382-7BFD-4910-AAF5-9D70140E1140Q37317317-C7B6FD57-2216-490A-8397-BC7FFDCE7060Q37369189-106FD85F-1B74-4F81-A4EB-3F65FC5AFE69Q37448141-F23D360D-E51E-471C-B0F2-8CBDA518BECDQ37538046-51E54701-65E0-41EE-9005-F396A251291EQ37587645-C474C86F-41E4-4C22-90BE-170A710F1ED9Q37688786-AE176325-B166-4822-A7DE-5B9713B3E743Q37814068-95C6A3D4-096D-4200-B156-6F92EA0C1650Q37846231-2987753C-E474-4A31-9148-A24BE8D0D761Q37875076-17291ECF-1F2B-4494-849F-18C7C6DEFE1AQ37995682-02A675BB-08C3-49BC-A8DD-33C1AE4810F6Q38003178-D8002139-B2D3-4827-8043-C4F6B59FC97DQ38103253-CFCF7BAA-15D1-4BCC-A906-FC9D0613D8ECQ38149113-DD8C5BCE-6976-4E7A-8F0E-D7B1C0B5948EQ38239700-686E2A06-F448-4EB8-AC67-64C433A97112Q38289055-4927A115-2660-43F2-AF44-FE4C025CD21DQ38493679-7957A49C-80E2-46D9-98BF-6B6E01F3943DQ38945828-090584DC-8699-4385-8306-40F69D7A14EE
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
The tumor suppressor CYLD regulates entry into mitosis
@ast
The tumor suppressor CYLD regulates entry into mitosis
@en
The tumor suppressor CYLD regulates entry into mitosis
@en-gb
The tumor suppressor CYLD regulates entry into mitosis
@nl
type
label
The tumor suppressor CYLD regulates entry into mitosis
@ast
The tumor suppressor CYLD regulates entry into mitosis
@en
The tumor suppressor CYLD regulates entry into mitosis
@en-gb
The tumor suppressor CYLD regulates entry into mitosis
@nl
prefLabel
The tumor suppressor CYLD regulates entry into mitosis
@ast
The tumor suppressor CYLD regulates entry into mitosis
@en
The tumor suppressor CYLD regulates entry into mitosis
@en-gb
The tumor suppressor CYLD regulates entry into mitosis
@nl
P2093
P2860
P50
P3181
P356
P1476
The tumor suppressor CYLD regulates entry into mitosis
@en
P2093
Frank Stegmeier
J Wade Harper
Mathew E Sowa
P2860
P304
P3181
P356
10.1073/PNAS.0703268104
P407
P577
2007-05-22T00:00:00Z